Candriam Equities L Biotech.I-H EUR Acc/ LU1006082199 /
| NAV04/06/2024 | Chg.+1.3599 | Type de rendement | Focus sur l'investissement | Société de fonds |
|---|---|---|---|---|
| 2,066.6399EUR | +0.07% | reinvestment | Equity Worldwide | Candriam ▶ |
Performance mensuelle
| janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | -23.24 | -4.43 | 3.75 | 3.78 | 5.33 | -8.43 | 12.46 | -2.53 | 3.75 | -12.49 | 8.75 | -2.94 | -19.97% |
| 2017 | 5.35 | 6.80 | -0.20 | 1.09 | -3.22 | 9.15 | 2.42 | 6.37 | 0.68 | -6.52 | 0.12 | 1.45 | +24.87% |
| 2018 | 6.60 | -4.86 | -2.17 | -3.34 | 4.39 | 0.63 | 4.29 | 3.92 | -2.21 | -14.22 | 3.85 | -8.55 | -13.02% |
| 2019 | 12.85 | 3.33 | -0.81 | -5.08 | -4.94 | 9.21 | -2.52 | -2.51 | -4.38 | 10.29 | 11.72 | 2.21 | +30.43% |
| 2020 | -5.35 | -1.19 | -5.42 | 12.40 | 9.51 | 1.27 | -2.96 | 0.83 | 0.64 | -2.75 | 9.44 | 2.92 | +18.93% |
| 2021 | 1.81 | -2.57 | -4.35 | 2.71 | -2.27 | 6.35 | -1.45 | 3.89 | -4.27 | 0.17 | -4.38 | 2.32 | -2.71% |
| 2022 | -10.88 | -1.96 | 5.39 | -7.76 | -3.50 | 2.63 | 4.48 | 0.83 | -2.35 | 6.56 | 5.77 | -3.11 | -5.50% |
| 2023 | 2.75 | -5.94 | 0.32 | 2.02 | -1.38 | 1.02 | -0.32 | -0.34 | -4.46 | -6.26 | 5.71 | 13.23 | +4.95% |
| 2024 | 1.22 | 1.20 | -0.07 | -6.27 | 4.01 | 1.80 | - | - | - | - | - | - | - |
Valeurs calculées
| CAD | 6 Mois | 1 An | 3 Ans | 5 Ans | |
|---|---|---|---|---|---|
| Volatilité | 15.87% | 17.18% | 16.19% | 20.07% | 22.64% |
| Ratio de Sharpe | 0.00 | 1.29 | 0.18 | -0.15 | 0.15 |
| Le meilleur mois | +13.23% | +13.23% | +13.23% | +13.23% | +13.23% |
| Le plus défavorable mois | -6.27% | -6.27% | -6.27% | -10.88% | -10.88% |
| Perte maximale | -11.21% | -11.21% | -15.74% | -30.29% | -32.04% |
| Surperformance | +1.76% | - | +1.73% | -5.87% | +3.46% |
Toutes les cotations dans EUR
Tranches
| Nom | Type de rendement | Prix de rachat | 1 An | 3 Ans | |
|---|---|---|---|---|---|
| Candriam Equities L Biotechnolog... | reinvestment | 2,064.5300 | +8.96% | +10.24% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 219.2800 | +6.24% | - | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,066.6399 | +6.61% | +2.51% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,213.3501 | +7.20% | +22.88% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,390.3999 | +5.73% | +20.61% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 355.5200 | +5.75% | +24.37% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 323.6500 | +7.23% | +25.39% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 200.9700 | +4.09% | +0.72% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,846.8199 | +9.19% | +13.00% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 149.4500 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 600.1300 | +7.57% | +8.05% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,648.7598 | +8.76% | +11.01% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 197.4500 | +5.75% | +2.03% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 205.9600 | +6.65% | +4.55% | |
| Candriam Equities L Biotech.R US... | reinvestment | 267.6600 | +8.82% | +13.33% | |
| Candriam Equities L Biotechnolo... | reinvestment | 842.5300 | +7.96% | +9.42% | |
| Candriam Equities L Biotechnolog... | paying dividend | 769.4600 | +7.93% | +9.31% |
Performance
| CAD | +1.60% | ||
|---|---|---|---|
| 6 Mois | +12.21% | ||
| 1 An | +6.61% | ||
| 3 Ans | +2.51% | ||
| 5 Ans | +41.57% | ||
| 10 ans | - | ||
| Depuis le début | +37.78% | ||
| Année | |||
| 2023 | +4.95% | ||
| 2022 | -5.50% | ||
| 2021 | -2.71% | ||
| 2020 | +18.93% | ||
| 2019 | +30.43% | ||
| 2018 | -13.02% | ||
| 2017 | +24.87% | ||
| 2016 | -19.97% | ||
